Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Inogen is a medical devices business based in the US. Inogen shares (INGN) are listed on the NASDAQ and all prices are listed in US Dollars. Inogen employs 1,021 staff and has a trailing 12-month revenue of around $365.6 million.
Finder Award
SoFi Invest
tastyworks
| Latest market close | $22.85 |
|---|---|
| 52-week range | $19.08 - $36.30 |
| 50-day moving average | $21.70 |
| 200-day moving average | $24.78 |
| Wall St. target price | $27.33 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.88 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $22.85 from 2023-01-27
| 1 week (2023-01-20) | 1.11% |
|---|---|
| 1 month (2022-12-28) | 19.38% |
| 3 months (2022-10-28) | 1.15% |
| 6 months (2022-07-28) | -13.68% |
| 1 year (2022-01-28) | -22.07% |
|---|---|
| 2 years (2021-01-28) | -53.26% |
| 3 years (2020-01-28) | 46.64 |
| 5 years (2018-01-26) | 125.75 |
Valuing Inogen stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inogen's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Inogen's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.48. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Inogen's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $365.6 million |
|---|---|
| Gross profit TTM | $176.5 million |
| Return on assets TTM | -4.69% |
| Return on equity TTM | -13.49% |
| Profit margin | -13.69% |
| Book value | $15.31 |
| Market capitalisation | $512.5 million |
TTM: trailing 12 months
We're not expecting Inogen to pay a dividend over the next 12 months.
Over the last 12 months, Inogen's shares have ranged in value from as little as $19.08 up to $36.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inogen's is 0.933. This would suggest that Inogen's shares are less volatile than average (for this exchange).
Inogen, Inc. , a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
